Cycloastragenol und Autophagie
Cycloastragenol » Autophagie
zur Cycloastragenol - HauptseiteCycloastragenol induces apoptosis and protective autophagy through AMPK/ULK1/mTOR axis in human non-small cell lung cancer cell lines
Cycloastragenol reduces microglial NLRP3 inflammasome activation in Parkinson's disease models by promoting autophagy and reducing Scrib-driven ROS
Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
Cycloastragenol restrains keratinocyte hyperproliferation by promoting autophagy via the miR-145/STC1/Notch1 axis in psoriasis
Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling
Dieser Beitrag unter abgelegt am 22 May 2026 von
Bitte Anmeldung kommentieren
Wissenschaftliche studien zu Cycloastragenol und Autophagie
- Cycloastragenol induces apoptosis and protective autophagy through AMPK/ULK1/mTOR axis in human non-small cell lung cancer cell lines
- Cycloastragenol reduces microglial NLRP3 inflammasome activation in Parkinson's disease models by promoting autophagy and reducing Scrib-driven ROS
- Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
- Cycloastragenol restrains keratinocyte hyperproliferation by promoting autophagy via the miR-145/STC1/Notch1 axis in psoriasis
- Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling
Ähnliche Fallstudien mit Cycloastragenol und Autophagie
In dieser Kategorie wurden keine Fallstudien veröffentlichtAktuelles zu Cycloastragenol und Autophagie
Aktuelles nicht gefunden
Stelle hier deine Frage an das Forum:
